1. Mahdi BM, Almukhtar M. Role of vaccines against COVID-19 pandemic. SLAS Discovery. 2023;28(8):355-357. doi:10.1016/j.slasd.2023. 07.002
2. Xie NN, Zhang WC, Chen J, Tian FB, Song JX. Clinical characteristics, diagnosis, and therapeutics of COVID-19: a review. Curr Med Sci. 2023; 43(6):1066-1074. doi:10.1007/s11596-023-2797-3
3. HenryBM,BenoitJL,BenoitS, et al. Red blood cell distribution width (RDW) predicts COVID-19 severity: a prospective, observational study from the Cincinnati SARS-CoV-2 emergency department cohort. Diagnostics (Basel). 2020;10(9):618. doi:10.3390/diagnostics10090618
4. Bouayed MZ, Laaribi I, Chatar CEM, et al. C-reactive protein (CRP): a poor prognostic biomarker in COVID-19. Front Immunol. 2022;14(13): 1040024. doi:10.3389/fimmu.2022.1040024
5. SuleimanAS,IslamMA,AkterMS,et al. A meta-meta-analysis of co-infection, secondary infections, and antimicrobial resistance in COVID-19 patients. J Infect Public Health.2023;16(10):1562-1590. doi: 10.1016/j.jiph.2023.07.005
6. Langford BJ, So M, Raybardhan S, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26:1622-1629. doi:10. 1016/j.cmi.2020.07.016
7. Ghahramani S, Tabrizi R, Lankarani KB, et al. Laboratory features of severe vs. non-severe COVID-19 patients Asian populations: systematic review and meta-analysis. Eur J Med Res. 2020;25(1):30. doi:10.1186/s40001-020-00432-3
8. DanartiR,LimantaraNV,RiniDLU, et al.Cutaneous manifestation in COVID-19: a lesson over 2 years into the pandemic. Clin Med Res. 2023; 21(1):36-45. doi:10.3121/cmr.2023.1598
9. Karimi A, Shobeiri P, Kulasinghe A, Rezaei N. Novel systemic inflammation markers to predict COVID-19 prognosis. Front Immunol. 2021;12:741061. doi:10.3389/fimmu.2021.741061
10. Yao Z, Zhang Y, Wu H. Regulation of C-reactive protein conformation in inflammation. Inflamm Res. 2019; 68:815-823. doi:10.1007/s00011-019-01269-1
11. Ho KM, Lee KY, Dobb GJ, Webb SA. C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a prospective cohort study. Int Care Med. 2008;34:481-487. doi:10.1007/s00134-007-0928-0
12. Rathore SS, Oberoi S, Iqbal K, et al. Prognostic value of novel serum biomarkers, including C-reactive protein to albumin ratio and fibrinogen to albumin ratio, in COVID-19 disease: a meta-analysis. Rev Med Virol. 2022:e2390. doi:10.1002/rmv.2390
13. KalabinA,ManiVR,ValdiviesoSC,DonaldsonB. Does C-reactive protein/albumin ratio have prognostic value in patients with COVID-19. J Infect Developing Countries.2021;15(8):1086-1093. doi:10. 3855/jidc.14826
14. Li Y, Li H, Song C, et al. Early prediction of diseaseprogression in patients with severe COVID-19 using C-reactive protein to albumin ratio. Disease Markers.2021;2021:6304189. doi:10.1155/2021/6304189
15. RamachandranP,GajendranM,PerisettiA,et al. Red blood cell distribution width in hospitalized COVID-19 patients. Front Med. 2022;7(8):582403. doi:10.3389/fmed.2021.582403
16. Mutlu NM, Peket TT, Soyal OB, et al. Red cell distribution width in diagnosis of brain death. Transplantation Proceedings. 2019;51(7):2189-2191. doi:10.1016/j.transproceed.2019.04.072
17. HongWS,RudasA,BellEJ,ChiangJN.Association of red blood cell distribution width with hospital admission and in-hospital mortality across all-cause adult emergency department visits. JAMIA Open. 2023; 6(3):ooad053. doi:10.1093/jamiaopen/ooad053
18. Chandler CM, Reid MC, Cherian S, Daniel E SabathDE, Edlefsen KL. Comparison of blood counts and markers of inflammation and coagulation in patients with and without COVID-19 presenting to the Emergency Department in Seattle, WA. Am J Clin Pathol. 2021;156(2): 185-197. doi:10.1093/ajcp/aqab052
19. Ertekin B, Acar T. The relationship between prognosis and red cell distribution width (RDW) and RDW-albumin ratio (RAR) in patients with severe COVID-19 disease. Int J General Med. 2022:15:8637-8645. doi:10.2147/IJGM.S392453
20. Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063-e1143. doi:10.1097/CCM. 0000000000005337
21. Zhu Y, Sharma L, Chang D. Pathophysiology and clinical management of coronavirus disease (COVID-19): a mini-review. Front Immunol. 2023;14:1116131. doi:10.3389/fimmu.2023.1116131
22. Bloria SD,Chauhan R,SarnaR,Gombar S,Jindal S. Comparison of APACHE II and APACHE IV score as predictors of mortality in patients with septic shock in intensive care unit: a prospective observational study. J Anaesthesiol Clin Pharmacol.2023;39(3):355-359. doi:10.4103/joacp.joacp_380_21
23. Budak F, Korkmaz Ş. General evaluation regarding the COVID-19 pandemic process: the example of Turkey. J Social Res Management. 2020;1:62-79. doi:10.35375/sayod.738657
24. Belinskaia DA, Voronina PA, Shmurak VI, Jenkins RO, Goncharov NV. Serum albumin in health and disease: esterase, antioxidant, transporting and signaling properties. Int J Molecular Sci. 2021;22(19): 10318. doi:10.3390/ijms221910318
25. Saravi B, Goebel U, Hassenzahl LO, et al. Capillary leak and endothelial permeability in critically ill patients: a current overview. Intens Care Med Experimental. 2023;11(1):96. doi:10.1186/s40635-023-00582-8
26. Aziz M, Fatima R, Lee-Smith W, Assaly R. The relationship between low serum albumin and severe COVID-19: a systematic review and meta-analysis. Crit Care. 2020;24:255. doi:10.1186/s13054-020-02995-3
27. Kalın BS, Solmaz İ. Prognostic role of red cell distribution width/albumin ratio and lactate dehydrogenase level in COVID-19 patients. Ege J Med. 2022;61(1):38-43. doi:10.19161/etd.1085634
28. Yılmaz N, Tosun F, Cömert E, Duran M, Tuna VD. The relationship of CRP/albumin ratio level and prognosis in pregnant COVID-19. Nigerian J Clin Practice. 2022;25(10):1745-1750. doi:10.4103/njcp.njcp_ 244_22
29. Uzum Y, Turkkan E. Predictivity of CRP, albumin, and CRP to albumin ratio on the development of intensive care requirement, mortality, and disease severity in COVID-19. Cureus. 2023;15(1):e33600. doi:10.7759/cureus.33600
30. Kim MH, Ahn JY, Song JE, et al. The C-reactive protein/albumin ratio as an independent predictor of mortality in patients with severe sepsis or septic shock treated with early goal-directed therapy. PLoS ONE. 2015;10(7):e0132109. doi:10.1371/journal.pone.0132109
31. Shan X, Li Z, Jiang J, et al. Prognostic value of red blood cell distribution width to albumin ratio for predicting mortality in adult patients meeting sepsis-3 criteria in intensive care units. BMC Anesthesiol. 2024; 24(1):208. doi:10.1186/s12871-024-02585-8
32. YooJW, JuS, LeeSJ, ChoYJ, LeeJD, KimHC. Red cell distribution width/albumin ratio is associated with 60-day mortality in patients with acute respiratory distress syndrome. Infect Dis.2020;52(4):266-270. doi:10.1080/23744235.2020.1717599
33. Jandaghian S, Vaezi A, Manteghinejad A, et al. Red blood cell distribution width (RDW) as a predictor of in-hospital mortality in COVID-19 patients; a cross sectional study. Arch Academic Emerg Med. 2021;9(1):e67. doi:10.22037/aaem.v9i1.1325